Global Nerve Repair and Regeneration
Global Nerve Repair and Regeneration

Nerve Repair and Regeneration Comprehensive Study by Type (Neurostimulation Devices, Neuromodulation Devices (Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)), Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors)), Application (Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Laboratories), Treatment Type (Direct Neuropathy, Nerve Grafting, Stem Cell Therapy, Neuromodulation Surgery) Players and Region - Global Market Outlook to 2026

Nerve Repair and Regeneration Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 208 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Nerve Repair and Regeneration Market Scope?
Nervous system injuries affect over 90,000 people each year. It is estimated that 10,000 spinal cord injuries are affected each year alone. As a result of this high incidence of neurological injury, nerve regeneration, and repair, a branch of neural tissue engineering, is becoming a rapidly growing area dedicated to the discovery of new ways to restore nerve functionality after injury. Peripheral nerves provide the path for all types of axons that make up the peripheral nervous system (PNS) (e.g., motor (afferent), sensory (efferent) axons). Injuries to these nerves are common diseases throughout the human body because of their poor physical protection (as opposed to the CNS, which is protected by bones and meningeal layers) and their superficial location. The repair and regeneration of nerves provide replacements for damaged nerve tissue, cells, and cell products. The mechanism for repairing and regenerating nerves involves the creation of new axons, myelin, neurons, glial cells, and synapses. Nerve injuries are quite common and can be caused by either blunt trauma or traction injuries.

The Nerve Repair and Regeneration market study is being classified by Type (Neurostimulation Devices, Neuromodulation Devices [Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)] and Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors]), by Application (Hospitals, Clinics, Ambulatory Surgery Centers and Diagnostic Laboratories) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Nerve Repair and Regeneration market throughout the predicted period.

Medtronic, PLC. (Ireland), Boston Scientific Corporation (United States), Abbott Laboratories (United States), AxoGen, Inc. (United States), Baxter International, Inc. (United States), LivaNova, PLC. (United Kingdom), Integra LifeSciences (United States), Polyganics (Netherlands), NeuroPace, Inc. (United States), Soterix Medical, Inc. (United States), Nevro Corp (United States), Synapse Biomedical, Inc. (United States), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (United States) and KeriMedical (Switzerland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are BioWave Corporation (United States), NeuroSigma (United States), tVNS Technologies GmbH(Germany) and GiMer Medical (Taiwan).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Nerve Repair and Regeneration market by Type, Application and Region.

On the basis of geography, the market of Nerve Repair and Regeneration has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In November 2017, AxoGen had further developed the nerve repair platform on its annual day. In addition to the existing portfolio for trauma to the upper extremities, oral and maxillofacial interventions as well as revision of the carpal and cubital tunnel; the company had expanded its portfolio so as to include the neurotization of breast reconstruction and the surgical treatment of pain.


Influencing Market Trend
  • A Rise in Availability of a Number of Therapies for Treating Various Central Nervous System (CNS) Disorders
  • The Rise in Favorable Reimbursement Policies, And the Strong Presence of Industry Players

Market Drivers
  • Rising Cases of Neurological Disorders and Strong Product Pipeline
  • The Growing Prevalence of Neurological Disorders
  • Increasing Awareness, Environmental Influence, Lifestyle, Genetics, Nutrition, and Physical Injuries
  • Increase in Peripheral Nerve Injuries and Neurological Disorders and Improvement in the Healthcare Facilities in Emerging Economies

Opportunities
  • Growing Expenditure on Healthcare, And Development of Innovative Technologies
  • Rising Government Support for Neurologic Disorder Research
  • Improved Treatment Efficiency for Neurological Disorders Due To Several Technological Advancements

Restraints
  • Stringent Regulatory Requirements for Product Approvals

Challenges
  • Lack of Awareness among Patients and Physicians about Nerve Repair and Regeneration Products and Techniques
  • Shortage of Skilled Professionals


Key Target Audience
Providers of Nerve Repair and Regeneration, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Neurostimulation Devices
  • Neuromodulation Devices [Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)]
  • Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors]
By Application
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Laboratories
By Treatment Type
  • Direct Neuropathy
  • Nerve Grafting
  • Stem Cell Therapy
  • Neuromodulation Surgery

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Cases of Neurological Disorders and Strong Product Pipeline
      • 3.2.2. The Growing Prevalence of Neurological Disorders
      • 3.2.3. Increasing Awareness, Environmental Influence, Lifestyle, Genetics, Nutrition, and Physical Injuries
      • 3.2.4. Increase in Peripheral Nerve Injuries and Neurological Disorders and Improvement in the Healthcare Facilities in Emerging Economies
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among Patients and Physicians about Nerve Repair and Regeneration Products and Techniques
      • 3.3.2. Shortage of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. A Rise in Availability of a Number of Therapies for Treating Various Central Nervous System (CNS) Disorders
      • 3.4.2. The Rise in Favorable Reimbursement Policies, And the Strong Presence of Industry Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nerve Repair and Regeneration, by Type, Application, Treatment Type and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Nerve Repair and Regeneration (Value)
      • 5.2.1. Global Nerve Repair and Regeneration by: Type (Value)
        • 5.2.1.1. Neurostimulation Devices
        • 5.2.1.2. Neuromodulation Devices [Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)]
        • 5.2.1.3. Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors]
      • 5.2.2. Global Nerve Repair and Regeneration by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgery Centers
        • 5.2.2.4. Diagnostic Laboratories
      • 5.2.3. Global Nerve Repair and Regeneration by: Treatment Type (Value)
        • 5.2.3.1. Direct Neuropathy
        • 5.2.3.2. Nerve Grafting
        • 5.2.3.3. Stem Cell Therapy
        • 5.2.3.4. Neuromodulation Surgery
      • 5.2.4. Global Nerve Repair and Regeneration Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Nerve Repair and Regeneration (Price)
      • 5.3.1. Global Nerve Repair and Regeneration by: Type (Price)
  • 6. Nerve Repair and Regeneration: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic, PLC. (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. AxoGen, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Baxter International, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. LivaNova, PLC. (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Integra LifeSciences (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Polyganics (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NeuroPace, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Soterix Medical, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Nevro Corp (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Synapse Biomedical, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Aleva Neurotherapeutics (Switzerland)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Collagen Matrix, Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. KeriMedical (Switzerland)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Nerve Repair and Regeneration Sale, by Type, Application, Treatment Type and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Nerve Repair and Regeneration (Value)
      • 7.2.1. Global Nerve Repair and Regeneration by: Type (Value)
        • 7.2.1.1. Neurostimulation Devices
        • 7.2.1.2. Neuromodulation Devices [Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)]
        • 7.2.1.3. Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors]
      • 7.2.2. Global Nerve Repair and Regeneration by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgery Centers
        • 7.2.2.4. Diagnostic Laboratories
      • 7.2.3. Global Nerve Repair and Regeneration by: Treatment Type (Value)
        • 7.2.3.1. Direct Neuropathy
        • 7.2.3.2. Nerve Grafting
        • 7.2.3.3. Stem Cell Therapy
        • 7.2.3.4. Neuromodulation Surgery
      • 7.2.4. Global Nerve Repair and Regeneration Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Nerve Repair and Regeneration (Price)
      • 7.3.1. Global Nerve Repair and Regeneration by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nerve Repair and Regeneration: by Type(USD Million)
  • Table 2. Nerve Repair and Regeneration Neurostimulation Devices , by Region USD Million (2015-2020)
  • Table 3. Nerve Repair and Regeneration Neuromodulation Devices [Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)] , by Region USD Million (2015-2020)
  • Table 4. Nerve Repair and Regeneration Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors] , by Region USD Million (2015-2020)
  • Table 5. Nerve Repair and Regeneration: by Application(USD Million)
  • Table 6. Nerve Repair and Regeneration Hospitals , by Region USD Million (2015-2020)
  • Table 7. Nerve Repair and Regeneration Clinics , by Region USD Million (2015-2020)
  • Table 8. Nerve Repair and Regeneration Ambulatory Surgery Centers , by Region USD Million (2015-2020)
  • Table 9. Nerve Repair and Regeneration Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 10. Nerve Repair and Regeneration: by Treatment Type(USD Million)
  • Table 11. Nerve Repair and Regeneration Direct Neuropathy , by Region USD Million (2015-2020)
  • Table 12. Nerve Repair and Regeneration Nerve Grafting , by Region USD Million (2015-2020)
  • Table 13. Nerve Repair and Regeneration Stem Cell Therapy , by Region USD Million (2015-2020)
  • Table 14. Nerve Repair and Regeneration Neuromodulation Surgery , by Region USD Million (2015-2020)
  • Table 15. South America Nerve Repair and Regeneration, by Country USD Million (2015-2020)
  • Table 16. South America Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 17. South America Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 18. South America Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 19. Brazil Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 20. Brazil Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 21. Brazil Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 22. Argentina Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 23. Argentina Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 24. Argentina Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 25. Rest of South America Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 26. Rest of South America Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 27. Rest of South America Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 28. Asia Pacific Nerve Repair and Regeneration, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 31. Asia Pacific Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 32. China Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 33. China Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 34. China Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 35. Japan Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 36. Japan Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 37. Japan Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 38. India Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 39. India Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 40. India Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 41. South Korea Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 42. South Korea Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 43. South Korea Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 44. Taiwan Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 45. Taiwan Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 46. Taiwan Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 47. Australia Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 48. Australia Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 49. Australia Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 53. Europe Nerve Repair and Regeneration, by Country USD Million (2015-2020)
  • Table 54. Europe Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 55. Europe Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 56. Europe Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 57. Germany Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 58. Germany Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 59. Germany Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 60. France Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 61. France Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 62. France Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 63. Italy Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 64. Italy Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 65. Italy Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 66. United Kingdom Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 67. United Kingdom Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 68. United Kingdom Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 69. Netherlands Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 70. Netherlands Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 71. Netherlands Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 72. Rest of Europe Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 74. Rest of Europe Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 75. MEA Nerve Repair and Regeneration, by Country USD Million (2015-2020)
  • Table 76. MEA Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 77. MEA Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 78. MEA Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 79. Middle East Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 80. Middle East Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 81. Middle East Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 82. Africa Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 83. Africa Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 84. Africa Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 85. North America Nerve Repair and Regeneration, by Country USD Million (2015-2020)
  • Table 86. North America Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 87. North America Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 88. North America Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 89. United States Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 90. United States Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 91. United States Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 92. Canada Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 93. Canada Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 94. Canada Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 95. Mexico Nerve Repair and Regeneration, by Type USD Million (2015-2020)
  • Table 96. Mexico Nerve Repair and Regeneration, by Application USD Million (2015-2020)
  • Table 97. Mexico Nerve Repair and Regeneration, by Treatment Type USD Million (2015-2020)
  • Table 98. Nerve Repair and Regeneration: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Nerve Repair and Regeneration: by Type(USD Million)
  • Table 115. Nerve Repair and Regeneration Neurostimulation Devices , by Region USD Million (2021-2026)
  • Table 116. Nerve Repair and Regeneration Neuromodulation Devices [Sacral Nerve Stimulation Devices (SNS), Vagus Nerve Stimulation Devices (VNS), Spinal Cord Stimulation Devices (SCS), Deep Brain Stimulation Devices (DBS), Gastric Electric Stimulation Devices (GES), Transcutaneous Electrical Nerve Stimulation (TENS), Transcranial Magnetic Stimulation (TMS)] , by Region USD Million (2021-2026)
  • Table 117. Nerve Repair and Regeneration Biomaterials [Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors] , by Region USD Million (2021-2026)
  • Table 118. Nerve Repair and Regeneration: by Application(USD Million)
  • Table 119. Nerve Repair and Regeneration Hospitals , by Region USD Million (2021-2026)
  • Table 120. Nerve Repair and Regeneration Clinics , by Region USD Million (2021-2026)
  • Table 121. Nerve Repair and Regeneration Ambulatory Surgery Centers , by Region USD Million (2021-2026)
  • Table 122. Nerve Repair and Regeneration Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 123. Nerve Repair and Regeneration: by Treatment Type(USD Million)
  • Table 124. Nerve Repair and Regeneration Direct Neuropathy , by Region USD Million (2021-2026)
  • Table 125. Nerve Repair and Regeneration Nerve Grafting , by Region USD Million (2021-2026)
  • Table 126. Nerve Repair and Regeneration Stem Cell Therapy , by Region USD Million (2021-2026)
  • Table 127. Nerve Repair and Regeneration Neuromodulation Surgery , by Region USD Million (2021-2026)
  • Table 128. South America Nerve Repair and Regeneration, by Country USD Million (2021-2026)
  • Table 129. South America Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 130. South America Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 131. South America Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 132. Brazil Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 133. Brazil Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 134. Brazil Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 135. Argentina Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 136. Argentina Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 137. Argentina Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 138. Rest of South America Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 139. Rest of South America Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 140. Rest of South America Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 141. Asia Pacific Nerve Repair and Regeneration, by Country USD Million (2021-2026)
  • Table 142. Asia Pacific Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 143. Asia Pacific Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 144. Asia Pacific Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 145. China Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 146. China Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 147. China Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 148. Japan Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 149. Japan Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 150. Japan Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 151. India Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 152. India Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 153. India Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 154. South Korea Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 155. South Korea Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 156. South Korea Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 157. Taiwan Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 158. Taiwan Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 159. Taiwan Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 160. Australia Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 161. Australia Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 162. Australia Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 163. Rest of Asia-Pacific Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 164. Rest of Asia-Pacific Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 165. Rest of Asia-Pacific Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 166. Europe Nerve Repair and Regeneration, by Country USD Million (2021-2026)
  • Table 167. Europe Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 168. Europe Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 169. Europe Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 170. Germany Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 171. Germany Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 172. Germany Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 173. France Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 174. France Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 175. France Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 176. Italy Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 177. Italy Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 178. Italy Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 179. United Kingdom Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 180. United Kingdom Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 181. United Kingdom Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 182. Netherlands Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 183. Netherlands Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 184. Netherlands Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 185. Rest of Europe Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 186. Rest of Europe Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 187. Rest of Europe Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 188. MEA Nerve Repair and Regeneration, by Country USD Million (2021-2026)
  • Table 189. MEA Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 190. MEA Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 191. MEA Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 192. Middle East Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 193. Middle East Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 194. Middle East Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 195. Africa Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 196. Africa Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 197. Africa Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 198. North America Nerve Repair and Regeneration, by Country USD Million (2021-2026)
  • Table 199. North America Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 200. North America Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 201. North America Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 202. United States Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 203. United States Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 204. United States Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 205. Canada Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 206. Canada Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 207. Canada Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 208. Mexico Nerve Repair and Regeneration, by Type USD Million (2021-2026)
  • Table 209. Mexico Nerve Repair and Regeneration, by Application USD Million (2021-2026)
  • Table 210. Mexico Nerve Repair and Regeneration, by Treatment Type USD Million (2021-2026)
  • Table 211. Nerve Repair and Regeneration: by Type(USD/Units)
  • Table 212. Research Programs/Design for This Report
  • Table 213. Key Data Information from Secondary Sources
  • Table 214. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nerve Repair and Regeneration: by Type USD Million (2015-2020)
  • Figure 5. Global Nerve Repair and Regeneration: by Application USD Million (2015-2020)
  • Figure 6. Global Nerve Repair and Regeneration: by Treatment Type USD Million (2015-2020)
  • Figure 7. South America Nerve Repair and Regeneration Share (%), by Country
  • Figure 8. Asia Pacific Nerve Repair and Regeneration Share (%), by Country
  • Figure 9. Europe Nerve Repair and Regeneration Share (%), by Country
  • Figure 10. MEA Nerve Repair and Regeneration Share (%), by Country
  • Figure 11. North America Nerve Repair and Regeneration Share (%), by Country
  • Figure 12. Global Nerve Repair and Regeneration: by Type USD/Units (2015-2020)
  • Figure 13. Global Nerve Repair and Regeneration share by Players 2020 (%)
  • Figure 14. Global Nerve Repair and Regeneration share by Players (Top 3) 2020(%)
  • Figure 15. Global Nerve Repair and Regeneration share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Medtronic, PLC. (Ireland) Revenue, Net Income and Gross profit
  • Figure 18. Medtronic, PLC. (Ireland) Revenue: by Geography 2020
  • Figure 19. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 21. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 22. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 23. AxoGen, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. AxoGen, Inc. (United States) Revenue: by Geography 2020
  • Figure 25. Baxter International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Baxter International, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. LivaNova, PLC. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. LivaNova, PLC. (United Kingdom) Revenue: by Geography 2020
  • Figure 29. Integra LifeSciences (United States) Revenue, Net Income and Gross profit
  • Figure 30. Integra LifeSciences (United States) Revenue: by Geography 2020
  • Figure 31. Polyganics (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. Polyganics (Netherlands) Revenue: by Geography 2020
  • Figure 33. NeuroPace, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. NeuroPace, Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Soterix Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Soterix Medical, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Nevro Corp (United States) Revenue, Net Income and Gross profit
  • Figure 38. Nevro Corp (United States) Revenue: by Geography 2020
  • Figure 39. Synapse Biomedical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Synapse Biomedical, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Aleva Neurotherapeutics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Aleva Neurotherapeutics (Switzerland) Revenue: by Geography 2020
  • Figure 43. Collagen Matrix, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Collagen Matrix, Inc. (United States) Revenue: by Geography 2020
  • Figure 45. KeriMedical (Switzerland) Revenue, Net Income and Gross profit
  • Figure 46. KeriMedical (Switzerland) Revenue: by Geography 2020
  • Figure 47. Global Nerve Repair and Regeneration: by Type USD Million (2021-2026)
  • Figure 48. Global Nerve Repair and Regeneration: by Application USD Million (2021-2026)
  • Figure 49. Global Nerve Repair and Regeneration: by Treatment Type USD Million (2021-2026)
  • Figure 50. South America Nerve Repair and Regeneration Share (%), by Country
  • Figure 51. Asia Pacific Nerve Repair and Regeneration Share (%), by Country
  • Figure 52. Europe Nerve Repair and Regeneration Share (%), by Country
  • Figure 53. MEA Nerve Repair and Regeneration Share (%), by Country
  • Figure 54. North America Nerve Repair and Regeneration Share (%), by Country
  • Figure 55. Global Nerve Repair and Regeneration: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Medtronic, PLC. (Ireland)
  • Boston Scientific Corporation (United States)
  • Abbott Laboratories (United States)
  • AxoGen, Inc. (United States)
  • Baxter International, Inc. (United States)
  • LivaNova, PLC. (United Kingdom)
  • Integra LifeSciences (United States)
  • Polyganics (Netherlands)
  • NeuroPace, Inc. (United States)
  • Soterix Medical, Inc. (United States)
  • Nevro Corp (United States)
  • Synapse Biomedical, Inc. (United States)
  • Aleva Neurotherapeutics (Switzerland)
  • Collagen Matrix, Inc. (United States)
  • KeriMedical (Switzerland)
Additional players considered in the study are as follows:
BioWave Corporation (United States) , NeuroSigma (United States) , tVNS Technologies GmbH(Germany) , GiMer Medical (Taiwan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation